Interferon beta-1a–induced morphea

JAAD Case Reports - Tập 1 Số 1 - Trang 15-17 - 2015
Spencer A. Bezalel1, Bruce Strober2,3, Katalin Ferenczi2
1University of South Florida Morsani College of Medicine, Tampa, Florida
2Department of Dermatology, University of Connecticut School of Medicine. Farmington, Connecticut
3Probity Medical Research, Waterloo, Ontario, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Walther, 1999, Multiple sclerosis: Side effects of interferon beta therapy and their management, Neurology, 53, 1622, 10.1212/WNL.53.8.1622

Hugle, 2009, Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology, or interferon induced?, Ann Rheum Dis, 68, 47, 10.1136/ard.2007.083246

Fett, 2011, Update on morphea, J Am Acad Dermatol, 64, 217, 10.1016/j.jaad.2010.05.045

Sartori-Valinotti, 2013, Updates on Morphea: Role of Vascular Injury and Advances in Treatment, Autoimmune Dis, 2013, 1, 10.1155/2013/467808

Grabell, 2014, The role of skin trauma in the distribution of morphea lesions: A cross-sectional survey of the Morphea in Adults and Children cohort IV, J Am Acad Dermatol, 71, 493, 10.1016/j.jaad.2014.04.009

Ramirez, 2012, Morphea associated with the use of adalimumab: a case report and review of the literature, Mod Rheumatol, 22, 602, 10.3109/s10165-011-0550-4

Needleman, 1992, Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and intereferon-gamma levels in sera from patients with scleroderma, Arthritis Rheum, 35, 67, 10.1002/art.1780350111

Ochi, 2004, Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b, J Neurol Sci, 222, 65, 10.1016/j.jns.2004.04.012

Hogaboam, 1998, Novel roles for chemokines and fibroblasts in interstitial fibrosis, Kidney Int, 54, 2152, 10.1046/j.1523-1755.1998.00176.x

Lebrun, 2011, Cutaneous Side-effects of Immunomodulators in MS, Int MS J, 17, 88